hotspot -WSS

hotspot

author：comprehensive 2025-09-27 11:58:15 - browse：123

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Kristina Burow of ARCH Venture Partners shares her next big bets STAT

entertainment

WSS

As pharma fights Medicare drug negotiation, hospitals, docs silent

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

FogPharma raises $145 million in rare Series E round

Pfizer highlights cancer drugs it thinks could reignite investor interest

In science, is the line between industry and academia shifting?

FDA does about

hotspot

hotspot

focus

Medical records are filled with copy

What do new weight loss drugs mean for bariatric surgery?

Moonlake's readout produced a cash windfall. Risks remain

Appeals court upholds limits to abortion pill

New air purifier tech could be key to improving indoor air quality

RaDonda Vaught to speak at CommonSpirit event on patient safety

Medical records are filled with copy

2024 GOP presidential candidates spar over abortion in debate

Supreme Court strikes down use of affirmative action

Study finds new variant for Parkinson’s in African populations

hotspot

Winners, losers from Medicare’s list of drugs subject to price talks

Why more medical students aren't specializing in primary care

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

AstraZeneca bets AAV gene therapy will still deliver the goods

Obesity now affects over 1 billion people worldwide, study finds

House looks to weaken Medicare negotiation

hotspot

focus

entertainment

Wikipedia